Tempo Therapeutics, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Tempo Therapeutics, Inc. - overview
Established
2014
Location
San Diego, CA, US
Primary Industry
Biotechnology
About
Founded in 2014 by Westbrook Weaver (CEO) and Donald Griffin (CSO), and based in California, US, Tempo Therapeutics, Inc. operates as a biotechnology research company that develops and manufactures tissue engineering solutions for regenerative medicine using its Microporous Annealed Particle technology. In March 2024, Tempo Therapeutics, Inc. raised USD 16.
33 million in Series A funding co-led by investors Johnson & Johnson Innovation and Galaxy Sirius Partners, with participation from other investors. The firm pioneers tissue engineering biotechnology using its proprietary MAP (Microporous Annealed Particle) material science technology. MAP enables the creation of injectable porous scaffolds for regenerative medicine, modulating patients' immune cells for regenerative responses. Their biosurgery products address soft tissue reconstructions, improving outcomes by promoting tissue strength and function.
Additionally, Tempo develops novel therapies in various therapeutic areas using MAP technology. The company intends to use the March 2024 funding to take its synthetic tissue scaffold candidates into clinical trials and advance its Microporous-Annealed-Particle (MAP) technology platform.
Current Investors
Johnson & Johnson Innovation
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biotechnology, Biomaterials
Website
www.tempothera.com
Verticals
HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.